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TO THE EDITOR
As skin ages, the epidermis is thinner
with reduced epidermal proliferation,
abnormal differentiation, impaired lipid
synthesis, and elevated skin surface pH.
These alterations have profound
consequences for barrier function, skin
cohesion, antimicrobial defense, inflam-
matory threshold, and cutaneous wound
healing (Ghadially et al., 1995; Mauro
et al., 1998; Choi et al., 2007;
Rodriguez-Martin et al., 2011). These
abnormalities have been linked, in part,
to reduced epidermal IL-1a expression
(Ye et al., 2002), reduced epidermal
expression of CD44 and its ligand, hya-
luronic acid (Bourguignon et al., 2013),
and reduced epidermal lipid synthesis.
Among these many changes, much
attention has been paid to the epidermal
permeability barrier, because of its
dominant role in regulating cutaneous
homeostasis. Studies have demonstrated
that epidermal permeability barrier
regulates epidermal proliferation, differ-
entiation, lipid production, and innate
immunity. Therefore, strategies that
enhance epidermal proliferation, differ-
entiation, and/or lipid production, while
also reducing stratum corneum (SC) pH,
could prove to be useful for preventing
and/or treating the functional abnormal-
ities, including permeability barrier
homeostasis, in aged skin. Our previous
studies demonstrated that topical appli-
cations of a readily available herbal
ingredient, hesperidin, improve epider-
mal permeability barrier function in
young mice by stimulating epidermal
proliferation, differentiation, and lamel-
lar body formation/secretion (Hou et al.,
2012), all of which are likely indepen-
dent of the antioxidant properties of
hesperidin. Here, we show that topical
applications of hesperidin improve multi-
ple key epidermal functions in aged
mouse skin. After 9 days of treatment,
the gross appearance of mouse skin
treated with vehicle and hesperidin
appeared similar. Histological analysis
showed that aged epidermis was thinner
than young epidermis; whereas prolife-
rating cell nuclear antigen (PCNA)
staining indicated that aged epidermis
displayed less robust proliferative activity
as compared with young epidermis;
hesperidin treatment did not stimulate
epidermal proliferation in aged skin, as
indicated by PCNA-positive cells per cm
epidermal length (2.70±0.10 vs. 2.45±
0.13 for vehicle-treated vs. hesperidin-
treated skin, NS; 3.46±0.17 for young
skin; young vs. vehicle- or hesperidin-
treated aged skin, Po0.001). These
results indicate that topical hesperidin
does not stimulate epidermal prolifera-
tion in aged mice.
After 9 days of topical hesperidin
treatment, baseline SC hydration in
hesperidin-treated mice also was noAccepted article preview online 17 November 2014; published online 18 December 2014
Abbreviations: ABCA12, ATP-binding cassette transporter 12; FAS, fatty acid synthase; hBD2, human beta-
defensin 2; HMGCoA, 3-hydroxy-3-methyl-glutaryl-CoA reductase; mBD3, mouse beta-defensin 3; NHE1,
sodium/hydrogen exchanger 1; Nrf2, nuclear factor (erythroid-derived 2)–like 2; PCNA, proliferating cell
nuclear antigen; Q-PCR, quantitative reverse transcriptase in real time; SC, stratum corneum; sPLA2,
secretory phospholipase A2; SPT, serine palmitoyltransferase 1
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different from that in vehicle-treated
mice (60.77±1.32 for vehicle-treated
vs. 58.80±2.27 for hesperidin-treated).
However, skin surface pH significantly
declined in hesperidin-treated skin
compared with vehicle-treated skin
(Figure 1a). Although basal transepider-
mal water loss rates increased slightly in
hesperidin-treated skin as compared
with vehicle-treated skin (Figure 1a),
these levels still fell well within the
normal range of young skin. Consistent
with previous findings in young mice
(Hou et al., 2012), topical hesperidin
significantly accelerated barrier
recovery at both 2 and 4 hours after
acute barrier disruption of aged skin
(Figure 1b). These results demonstrate
that topical hesperidin improves epider-
mal permeability barrier homeostasis,
while also lowering skin surface pH in
aged murine skin.
We next examined the basis for
improved barrier function and acidifica-
tion in aged epidermis. Our previous
studies demonstrated that topical hes-
peridin stimulates epidermal differentia-
tion, accounting in part for improved
epidermal permeability barrier homeos-
tasis in young mice. Hence, we next
assessed whether topical hesperidin also
stimulates epidermal differentiation in
aged epidermis. As shown in Figure 1c,
topical hesperidin significantly incre-
sed the mRNA levels of filaggrin and
loricrin in aged mouse epidermis, con-
sistent with the results of immunostain-
ing (Supplementary Figure S1 online).
Consistently, hesperidin also increased
the mRNA levels of filaggrin, involucrin,
and loricrin in adult keratinocyte cul-
tures (Figure 1d). These results indicate
that hesperidin stimulates epidermal dif-
ferentiation, providing one potential
mechanism whereby hesperidin impro-
ves barrier function in aged skin.
Epidermal lipid synthesis is required
for the formation and maintenance of the
epidermal permeability barrier. Synthesis
of three key barrier-related lipids, choles-
terol ceramides, and fatty acids requires
their respective rate-limiting enzymes 3-
hydroxy-3-methyl-glutaryl-CoA reductase
(HMGCoA), serine palmitoyltransferase 1
(SPT1), and fatty acid synthase (FAS).
Basal mRNA levels for all three key lipid
synthetic enzymes were lower in aged as
compared with young epidermis (demon-
strated by the dotted line in Figure 1e),
consistent with the concept that the
lower lipid synthesis rates in aged epi-
dermis could reflect the reduced expres-
sion of their synthetic enzymes. Topical
hesperidin treatment significantly
increased the mRNA levels of HMGCoA,
SPT1, and FAS in aged mouse epidermis,
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Figure 1. Topical hesperidin improves epidermal permeability barrier homeostasis in aged murine skin. The values present the data in vivo in mice unless
otherwise specified. (a) Displays basal transepidermal water loss (TEWL) and skin surface pH in mice; (b) shows barrier recovery in mice; (c) shows the levels of
epidermal mRNA in mice; (d) exhibits the levels of mRNA expression in vitro in human keratinocyte cultures, expressed as the % of vehicle-treated samples setting
the levels of vehicle treated as 100% (dotted line); (e) shows epidermal mRNA levels in mice, expressed as the % of normal young mice setting the levels of young
mice as 100% (dotted line); (f) shows the results of quantitative analysis of lamellar body density and secretion in mice; (g and h) present the expression levels of
ATP-binding cassette transporter 12 (ABCA12) in mice and in vitro in human keratinocyte cultures, respectively; (i) shows the expression levels of epidermal
sodium/hydrogen exchanger 1 (NHE1) and secretory phospholipase A2 (sPLA2) in mice. Significances and numbers of samples are indicated in the figures.
G Man et al.
Hesperidin Improves Epidermal Barrier Function in Aged Skin
www.jidonline.org 1185
as assessed by quantitative reverse tran-
scriptase in real time (Q-PCR).
Epidermal permeability barrier func-
tion depends on newly synthesized epi-
dermal lipids delivered to the SC
through the secretion of lamellar bodies
from the stratum granulosum. Therefore,
we next assessed whether topical
hesperidin stimulates lamellar body for-
mation and/or secretion. As ATP-bind-
ing cassette transporter 12 (ABCA12), a
trans-membrane glycosylceramide trans-
porter, is required for normal lamellar
body assembly (Thomas et al., 2009),
we next evaluated the changes in
epidermal mRNA levels of ABCA12 in
hesperidin-treated aged epidermis.
Although untreated aged epidermis
displayed lower levels of ABCA12
mRNA in comparison with young mice,
topical hesperidin induced a marked
increase in ABCA12 mRNA expression
in aged mouse epidermis (Figure 1g) and
adult keratinocyte cultures (Figure 1h).
Although the density of lamellar bodies
did not increase in aged epidermis after
hesperidin treatment (Figure 1f), quan-
titative analyses revealed that the
extent of lamellar body secretion was
enhanced by topical hesperidin treat-
ment (Figure 1f). In comparison with
young epidermis, the increased number
of lamellar bodies in aged epidermis is
likely because of the retardation of
secretion. Together, these results suggest
that hesperidin induced an increase in
ABCA12 mRNA expression that results
in an apparent acceleration in the
delivery of newly synthesized lipids to
the SC.
Both epidermal sodium/hydrogen
exchanger 1 (NHE1) and secretory phos-
pholipase A2 (sPLA2; in particular
SPLAg2f) are key factors that selectively
influence the pH of the SC (Ilic et al.,
2014). Previous studies from our group
have shown that aged skin exhibits
higher pH (Choi et al., 2007), at least
partly owing to reduced NHE1
expression (Choi et al., 2007). To deter-
mine whether the hesperidin-induced
acidification of the pH of the SC
results from the upregulation of NHE1
and/or the parallel acidifying mech-
anism, sPLA2g2f, we next assessed the
changes in epidermal mRNA levels of
these two genes in aged epidermis after
herperidin treatments by Q-PCR.
Topical hesperidin provoked a marked
elevation in mRNA levels for both
NHE1 and sPLA2g2f in aged epidermis
(Figure 1i). These results suggest that
hesperidin-induced acidification of aged
epidermis results from stimulation of
NHE1 and sPLA2g2f, accounting for
the lower skin surface pH, and likely
improved epidermal permeability bar-
rier homeostasis in hesperidin-treated
aged mouse skin.
Our prior studies demonstrated that
epidermal permeability barrier and anti-
microbial function are co-regulated and
independent (Aberg et al., 2008). Aged
humans are predisposed to develop both
cutaneous and extracutaneous infec-
tions, and expression of the epidermal
cathelicidin antimicrobial peptide
CAMP/LL37 is reduced in aged skin
(Rodriguez-Martin et al., 2011). To
determine whether hesperidin enhan-
ces epidermal antimicrobial defense,
we next assessed changes in the
mRNA levels of mouse beta-defensin 3
(mBD3), a homolog of human beta-
defensin 2 (hBD2), following hes-
peridin treatment. Hesperidin treatment
significantly increased epidermal mBD3
mRNA levels (Supplementary Figure S2a
online). To further validate these in vivo
results, the effects of hesperidin on anti-
microbial mRNA expression were eval-
uated in cultured keratinocytes from
aged human skin. Although no changes
in constitutive hBD2 mRNA expression
were observed (Supplementary Figure
S2c online), the addition of hesperidin
to aged human keratinocyte cultures
markedly upregulated not only hBD3
mRNA but also CAMP/LL37 expression
(Supplementary Figure S2b and d online).
These results demonstrate that hesperidin
stimulates antimicrobial peptide mRNA
expression in aged keratinocytes.
In the present study, we demonstrated
that topical hesperidin improves a wide
spectrum of functional abnormalities
in aged epidermis, including abnorma-
lities in epidermal permeability barrier
function, epidermal differentiation,
lipid production, and SC acidification.
Although the molecular mechanisms of
hesperidin-induced functional changes
in aged skin is not clear, the antioxidant
property of hesperidin could be
involved. Aged skin displays lower
antioxidant capacity and excessive
accumulation of oxidative products,
and hesperidin shows high antioxidant
capacity (Pe˛kal et al., 2011). Hesperidin
inhibits the production of reactive
oxygen species in rat kidney and
human hepatocytes, reduces plasma
malondialdehyde levels, and increases
superoxide desmutase activity in
diabetic rats. Oral hesperidin admini-
stration increases blood glutathione
peroxidase activity in type 1 diabetic
patients, whereas antioxidants stimulate
keratinocyte differentiation. Our recent
study demonstrated that topical
hesperidin applications increased
epidermal mRNA levels of antioxidant
enzymes such as glutathione reductase
and superoxide dismutase in murine
skin (Man et al., 2014). Moreover,
antioxidants such as vitamin E and C
increase lipid production in keratinocyte
cultures. Pertinent to antioxidant,
nuclear factor (erythroid-derived 2)–like
2 (Nrf2), a transcription factor, regulates
epidermal differentiation and anti-
oxidant defense (Scha¨fer et al., 2012).
Nrf2 function is impaired in aged heart
(Gounder et al., 2012), and expression
levels were lower in aged epidermis
(unpublished observation by Man MQ
and Elias PM). Hesperidin upregulates
Nrf2 in the heart (Elavarasan et al.,
2012) and in the aged epidermis
(unpublished observation by Man MQ
and Elias PM). Hence, hesperidin-
induced improvement of epidermal
permeability barrier function in aged
skin may be mediated via Nrf2.
Nevertheless, this study indicates that
hesperidin could be a valuable appro-
ach for antiaging of skin.
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TO THE EDITOR
The keratin 16 gene (KRT16) encodes an
intermediate filament protein mainly
expressed in palmoplantar epidermis.
In humans, mutations in KRT16 are
responsible for pachyonychia congenita
and focal non-epidermolytic palmoplan-
tar keratoderma (FNEPPK; Smith et al.,
2000; McLean and Moore, 2011). One
of the main symptoms is a painful
thickening of the palms and soles. To
understand molecular mechanisms
involved in this keratoderma, Krt16 mu-
tant mouse models have been develo-
ped, but only one reproduces fully the
palmoplantar phenotype (Lessard and
Coulombe, 2012). In this study, we
present a spontaneous canine model of
FNEPPK inherited as an autosomal re-
cessive disorder in the Dogue de Borde-
aux breed. Because of its population
structure, which features genetic
isolates, the purebred dog model has
recently proven its utility in understand-
ing the molecular mechanisms of
hereditary cornification disorders, nota-
bly in humans and dog Autosomal
Recessive Congenital Ichthyosis (Grall
et al., 2012).
We investigated a family of 130 dogs
including 28 affected animals; no sex
bias was observed among the 13 males
and 15 females analyzed. The onset
usually occurred between 10 weeks
and 1 year of age. First described by
Paradis (1992), affected dogs exhibit a
painful thickening of the footpads with
severe keratinous proliferations and
fissures only at the ground contact
locations similar to those observed in
FNEPPK patients (Figure 1). Cracks pre-
dispose the dogs to secondary
infections, leading to lameness, causing
the dog to be reluctant to walk. Nails
did not seem to be affected, as reported
in some human FNEPPK patients and in
Krt16-null mice models (Shamsher
et al., 1995; Smith et al., 2000; Liao
et al., 2007; Lessard and Coulombe,
2012). Similarly, no other cutaneous
sign such as oral leukoplakia, cysts, or
follicular keratosis was reported. This is
concordant with our results of
quantitative reverse transcription PCR
of messsengerRNA from unaffected dog
biopsies, showing strong and specific
expression of KRT16 in the footpad,
nose, and keratinocytes but not in
body skin, oral mucosa, or other
organs (data not shown).
Histopathological examinations of
footpad biopsies revealed thick hyper-
keratotic digital epidermis that
was roughened by marked conical
papillae with a prominent ‘‘churchAccepted article preview online 18 December 2014; published online 15 January 2015
J Plassais et al.
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